Tropeano, Lauren Anne — Insider Profile

Insider Profile

Tropeano, Lauren Anne

🔒 Follow — get an alert on any new filing

$DCBO

Companies Filed At

Open-Market Buys (2yr)

$39K

Buy Value (2yr, open-market)

Jun 11, 2026

Most Recent Trade

Credibility
Score

Hit Rate

-10.5%

Avg 90d Return

-10.5%

Median 90d Return

Evaluated Trades

-10.5%

Best Trade

-10.5%

Worst Trade

Hit rate and returns are based on 4 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Cross-Company Track Record

THIN HISTORY

—

Hit Rate · 90d

-10.4%

Median Alpha · 90d

Closed Buys Evaluated

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 1 closed buys with individual return outcomes available on the Research plan.

Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days

$DCBO 54

Docebo

$7K · 1 buy

Last buy Jun 11, 2026

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Jun 11, 2026	$DCBO Docebo	—	Exercise	Sell	739	—	—	54
Jun 11, 2026	$DCBO Docebo	—	Open Market	Buy	367	$17.97	$7K	54
Jun 11, 2026	$DCBO Docebo	—	Exercise	Buy	739	—	—	54
Mar 31, 2026	$DCBO Docebo	—	Comp. Grant	Buy	35,117	—	—	54
Mar 11, 2026	$DCBO Docebo	—	Exercise	Sell	2,959	—	—	54
Mar 11, 2026	$DCBO Docebo	—	Exercise	Buy	2,959	—	—	54
Mar 11, 2026	$DCBO Docebo	—	Open Market	Buy	1,468	$22.32	$33K	54
Mar 11, 2025	$DCBO Docebo	—	Comp. Grant	Buy	26,157	—	—	54
Mar 11, 2025	$DCBO Docebo	—	Comp. Grant	Buy	26,157	—	—	54
Mar 11, 2025	$DCBO Docebo	—	Comp. Grant	Buy	26,157	—	—	54
Mar 11, 2025	$DCBO Docebo	—	Comp. Grant	Buy	11,835	—	—	54
Jan 07, 2025	$DCBO Docebo	—	Other	Sell	—	—	—	54
Jan 07, 2025	$DCBO Docebo	—	Other	Sell	—	—	—	54

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.